SAN FRANCISCO, May 18, 2017 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced study results presented during the European Stroke Organisation Conference in Prague. Findings reveal that Zio® by iRhythm extended continuous ambulatory monitoring is more […]
Rhythm
New Study Shows Medtronic Insertable Cardiac Monitors Detect High Rate of Atrial Fibrillation in Previously Undiagnosed High-Risk Patients
By GlobeNewswire DUBLIN and CHICAGO – May 12, 2017 -Medtronic plc (NYSE:MDT) today announced results from a new clinical study showing Medtronic Insertable Cardiac Monitors (ICM) detected a high incidence of atrial fibrillation (AF) in patients previously undiagnosed but suspected to be at high-risk for AF and stroke. These data […]
BioTelemetry Announces The Start Of The Tender Offer Period For LifeWatch Corp Shares
MALVERN, Pa. and ZUG, Switzerland, May 10, 2017 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the start of the main offer period of the tender offer […]
BioSig Technologies Release: PURE EP System Featured In The Journal Of Innovations In Cardiac Rhythm Management
Minneapolis, MN, May 09, 2017 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need for the $4+ billion electrophysiology (EP) marketplace, today announced that the Company’s co-authored manuscript with physicians from Mayo Clinic and Harvard Brigham […]
FDA Green Lights BIOTRONIK’s Sentus ProMRI Quadripolar Left Ventricular Lead
LAKE OSWEGO, Oregon, May 8, 2017 /PRNewswire/ — BIOTRONIK today announced FDA approval and the launch of Sentus ProMRI®, the thinnest quadripolar left ventricular lead available in the United States. This introduction completes BIOTRONIK’s second-generation ProMRI lead portfolio, which also includes Solia ProMRI and Plexa ProMRI. Sentus ProMRI is approved for […]
BIOTRONIK Nabs FDA OK of MultiPole Pacing with ProMRI: 360° Solutions for Patients With Heart Failure
LAKE OSWEGO, Ore., May 8, 2017 /PRNewswire/ — BIOTRONIK today announced FDA approval of the company’s MultiPole Pacing (MPP) technology, providing physicians with additional treatment options for heart failure patients who have been non-responsive to cardiac resynchronization therapy (CRT).1 MPP will be available on new BIOTRONIK CRT defibrillator (CRT-D) systems for […]
Boston Scientific (BSX) Snags FDA Approval for Resonate Family of High-Voltage Devices
MARLBOROUGH, Mass., May 9, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Resonate family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. The approval includes new features in the Resonate devices including SmartCRT technology with Multisite Pacing […]
Murj Launches Cardiac Device Data Management Platform at Heart Rhythm Society 2017
SANTA CRUZ, Calif.–(Business Wire)–Murj, Inc., a digital health company dedicated to helping clinicians streamline care for patients with implantable cardiac devices, today announced general availability of the company’s cloud-based, HIPAA-compliant application that consolidates data from all implantable cardiac device (CIED) types and manufacturers into an elegant, robust platform that delivers […]
Abbott (ABT) Announces CE Mark And First Use Of The World’s First Smartphone Compatible Insertable Cardiac Monitor
ABBOTT PARK, Ill., May 8, 2017 /PRNewswire/ — Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm Rx Insertable Cardiac Monitor (ICM), the world’s first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), to help guide therapy. […]
Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2017
MARLBOROUGH, Mass., May 3, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) today announced the schedule of key data presentations, including two late-breaking clinical trials, that will be featured at the 38th Annual Scientific Sessions of the Heart Rhythm Society in Chicago on May 10-13. Notably, the post-market approval data collected on […]
Recent
Innova Vascular’s Laguna® Thrombectomy System Surpasses Primary Endpoints in Pivotal TRUST Study for Pulmonary Embolism
Coreline Soft Receives U.S. FDA 510(k) Clearance for AVIEW Aorta Metrics, Expanding Its Chest CT AI Portfolio in the U.S.
CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
Popular
- No commented posts yet